Metaspray Nasal Spray

Indications

Metaspray Nasal Spray is indicated for treating nasal symptoms associated with seasonal and perennial allergic rhinitis in adults and pediatric patients aged 2 years and older. It is also prescribed for prophylaxis of nasal symptoms in adult and adolescent patients aged 12 years and older during the allergy season. Additionally, it is used for the treatment of nasal polyps in patients aged 18 years and older.

Pharmacology

Mometasone Furoate monohydrate, a corticosteroid with anti-inflammatory properties, is the active ingredient. Its precise mechanism of action is not fully understood but involves modulating various cell types and mediators involved in inflammation.

Dosage

For adults and children over 12 years, the recommended dose is two sprays (50 mcg each) in each nostril once daily for allergic rhinitis. Children aged 2 to 11 years should use one spray (50 mcg each) in each nostril once daily. Adults aged 18 years and older with nasal polyps should use two sprays (50 mcg each) in each nostril twice daily.

Administration

Shake the bottle gently, remove the dust cover, and prime the pump if using it for the first time or after a week of non-use. Gently blow the nose, insert the nasal applicator into one nostril, and spray while inhaling through the nose. Repeat for the other nostril. Clean the nasal spray once a week by removing the dust cover, pulling off the nasal applicator, washing them, and letting them air dry.

Interaction

No significant drug interactions have been reported with Metaspray.

Contraindications

Hypersensitivity to any of the ingredients prohibits the use of Metaspray.

Side Effects

Common side effects include headache, viral infection, sore throat, nosebleeds, and coughing.

Pregnancy & Lactation

Use during pregnancy should be based on a risk-benefit assessment, as there are limited studies on its safety. Caution is advised during lactation due to potential excretion in human milk.

Precautions & Warnings

Caution is advised in patients with certain infections, including tuberculosis and ocular herpes simplex, while using nasal corticosteroids.

Overdose Effects

Overdose is unlikely to require specific therapy due to low systemic bioavailability and minimal acute systemic effects observed in clinical studies.

Therapeutic Class

Metaspray belongs to the therapeutic class of Nasal Steroid Preparations.

Storage Conditions

Store below 30°C, away from light and moisture, and keep out of the reach of children.